APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-driven Peptide Drug Discovery Platform

Compare research editions
View pricing & licenses

Selected research

Industry Research

AI-driven Peptide Drug Discovery Platform Industry Research Report 2026

5 June 2026133 pages

Choose your research edition.

Industry ResearchAI-driven Peptide Drug Discovery Platform Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-driven Peptide Drug Discovery Platform Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal AI-driven Peptide Drug Discovery Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-driven Peptide Drug Discovery Platform Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-driven Peptide Drug Discovery Platform Market Analysis and Forecast 2026-2032257 pages · $4,950 USD

Market perspective

The global AI-driven Peptide Drug Discovery Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the AI-driven Peptide Drug Discovery Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI-driven Peptide Drug Discovery Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI-driven Peptide Drug Discovery Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI-driven Peptide Drug Discovery Platform include Peptilogics, Pepticom Ltd, Menten AI, GUBRA, Creative Peptides, Exscalate, Generate Biomedicines, Receptor.AI and Insilico Medicine, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global AI-driven Peptide Drug Discovery Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI-driven Peptide Drug Discovery Platform.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

AI-driven Peptide Drug Discovery Platform Market by Company

Peptilogics

Pepticom Ltd

Menten AI

GUBRA

Creative Peptides

Exscalate

Generate Biomedicines

Receptor.AI

Insilico Medicine

Schrödinger

BenevolentAI

Evotec

PeptiFinder

Xtalpi

Sun Novo

Zonsen Peplib Biotech

Tide Tron Biotech

AI-driven Peptide Drug Discovery Platform Segment by Type

Design and Generation Platform

Screening and Optimization Platform

Data-driven Platform

Others

AI-driven Peptide Drug Discovery Platform Segment by Application

Scientific Research

Pharmaceuticals

AI-driven Peptide Drug Discovery Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-driven Peptide Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-driven Peptide Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-driven Peptide Drug Discovery Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of AI-driven Peptide Drug Discovery Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global AI-driven Peptide Drug Discovery Platform Market Size by Type (2021-2026) & (US$ Million) Table 6. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2021-2026) Table 7. Global AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2027-2032) Table 9. Global AI-driven Peptide Drug Discovery Platform Market Size by Application (2021-2026) & (US$ Million) Table 10. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2021-2026) Table 11. Global AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2027-2032) Table 13. Global AI-driven Peptide Drug Discovery Platform Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2021-2026) & (US$ Million) Table 15. Global AI-driven Peptide Drug Discovery Platform Market Share by Region (2021-2026) Table 16. Global AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global AI-driven Peptide Drug Discovery Platform Market Share by Region (2027-2032) Table 18. AI-driven Peptide Drug Discovery Platform Industry Trends Table 19. AI-driven Peptide Drug Discovery Platform Industry Drivers Table 20. AI-driven Peptide Drug Discovery Platform Industry Opportunities and Challenges Table 21. AI-driven Peptide Drug Discovery Platform Market Restraints Table 22. Global Top AI-driven Peptide Drug Discovery Platform Players by Revenue (US$ Million) & (2021-2026) Table 23. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Players (2021-2026) Table 24. Global AI-driven Peptide Drug Discovery Platform Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of AI-driven Peptide Drug Discovery Platform, Headquarters and Area Served Table 26. Global AI-driven Peptide Drug Discovery Platform Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global AI-driven Peptide Drug Discovery Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million) Table 32. North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific AI-driven Peptide Drug Discovery Platform Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032) & (US$ Million) Table 39. South America AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million) Table 41. South America AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032) & (US$ Million) Table 45. Peptilogics Company Information Table 46. Peptilogics Business Overview Table 47. Peptilogics Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 48. Peptilogics AI-driven Peptide Drug Discovery Platform Product Portfolio Table 49. Peptilogics Recent Developments Table 50. Pepticom Ltd Company Information Table 51. Pepticom Ltd Business Overview Table 52. Pepticom Ltd Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 53. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Portfolio Table 54. Pepticom Ltd Recent Developments Table 55. Menten AI Company Information Table 56. Menten AI Business Overview Table 57. Menten AI Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 58. Menten AI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 59. Menten AI Recent Developments Table 60. GUBRA Company Information Table 61. GUBRA Business Overview Table 62. GUBRA Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 63. GUBRA AI-driven Peptide Drug Discovery Platform Product Portfolio Table 64. GUBRA Recent Developments Table 65. Creative Peptides Company Information Table 66. Creative Peptides Business Overview Table 67. Creative Peptides Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 68. Creative Peptides AI-driven Peptide Drug Discovery Platform Product Portfolio Table 69. Creative Peptides Recent Developments Table 70. Exscalate Company Information Table 71. Exscalate Business Overview Table 72. Exscalate Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 73. Exscalate AI-driven Peptide Drug Discovery Platform Product Portfolio Table 74. Exscalate Recent Developments Table 75. Generate Biomedicines Company Information Table 76. Generate Biomedicines Business Overview Table 77. Generate Biomedicines Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 78. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Portfolio Table 79. Generate Biomedicines Recent Developments Table 80. Receptor.AI Company Information Table 81. Receptor.AI Business Overview Table 82. Receptor.AI Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 83. Receptor.AI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 84. Receptor.AI Recent Developments Table 85. Insilico Medicine Company Information Table 86. Insilico Medicine Business Overview Table 87. Insilico Medicine Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 88. Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Portfolio Table 89. Insilico Medicine Recent Developments Table 90. Schrödinger Company Information Table 91. Schrödinger Business Overview Table 92. Schrödinger Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 93. Schrödinger AI-driven Peptide Drug Discovery Platform Product Portfolio Table 94. Schrödinger Recent Developments Table 95. BenevolentAI Company Information Table 96. BenevolentAI Business Overview Table 97. BenevolentAI Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 98. BenevolentAI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 99. BenevolentAI Recent Developments Table 100. Evotec Company Information Table 101. Evotec Business Overview Table 102. Evotec Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 103. Evotec AI-driven Peptide Drug Discovery Platform Product Portfolio Table 104. Evotec Recent Developments Table 105. PeptiFinder Company Information Table 106. PeptiFinder Business Overview Table 107. PeptiFinder Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 108. PeptiFinder AI-driven Peptide Drug Discovery Platform Product Portfolio Table 109. PeptiFinder Recent Developments Table 110. Xtalpi Company Information Table 111. Xtalpi Business Overview Table 112. Xtalpi Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 113. Xtalpi AI-driven Peptide Drug Discovery Platform Product Portfolio Table 114. Xtalpi Recent Developments Table 115. Sun Novo Company Information Table 116. Sun Novo Business Overview Table 117. Sun Novo Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 118. Sun Novo AI-driven Peptide Drug Discovery Platform Product Portfolio Table 119. Sun Novo Recent Developments Table 120. Zonsen Peplib Biotech Company Information Table 121. Zonsen Peplib Biotech Business Overview Table 122. Zonsen Peplib Biotech Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 123. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio Table 124. Zonsen Peplib Biotech Recent Developments Table 125. Tide Tron Biotech Company Information Table 126. Tide Tron Biotech Business Overview Table 127. Tide Tron Biotech Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026) & (US$ Million) Table 128. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio Table 129. Tide Tron Biotech Recent Developments Table 130. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. AI-driven Peptide Drug Discovery Platform Product Image Figure 5. Global AI-driven Peptide Drug Discovery Platform Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global AI-driven Peptide Drug Discovery Platform Market Share by Type: 2025 VS 2032 Figure 7. Design and Generation Platform Product Figure 8. Screening and Optimization Platform Product Figure 9. Data-driven Platform Product Figure 10. Others Product Figure 11. Global AI-driven Peptide Drug Discovery Platform Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global AI-driven Peptide Drug Discovery Platform Market Share by Application: 2025 VS 2032 Figure 13. Scientific Research Product Figure 14. Pharmaceuticals Product Figure 15. Global AI-driven Peptide Drug Discovery Platform Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global AI-driven Peptide Drug Discovery Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global AI-driven Peptide Drug Discovery Platform Market Share by Region: 2025 VS 2032 Figure 18. Global AI-driven Peptide Drug Discovery Platform Market Share by Players in 2025 Figure 19. Global AI-driven Peptide Drug Discovery Platform Manufacturers Established Date Figure 20. Global Top 5 and 10 AI-driven Peptide Drug Discovery Platform Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 24. United States AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 27. Europe AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 29. Germany AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 39. China AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 44. Australia AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America AI-driven Peptide Drug Discovery Platform Market Share by Country (2021-2032) Figure 49. Brazil AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru AI-driven Peptide Drug Discovery Platform Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peptilogics Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 55. Pepticom Ltd Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 56. Menten AI Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 57. GUBRA Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 58. Creative Peptides Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 59. Exscalate Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 60. Generate Biomedicines Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 61. Receptor.AI Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 62. Insilico Medicine Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 63. Schrödinger Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 64. BenevolentAI Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 65. Evotec Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 66. PeptiFinder Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 67. Xtalpi Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 68. Sun Novo Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 69. Zonsen Peplib Biotech Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026) Figure 70. Tide Tron Biotech Revenue Growth Rate in AI-driven Peptide Drug Discovery Platform Business (2021-2026)

Scope & coverage.

Types
  • Design and Generation Platform
  • Screening and Optimization Platform
  • Data-driven Platform
  • Others
Applications
  • Scientific Research
  • Pharmaceuticals
Companies covered
  • Peptilogics
  • Pepticom Ltd
  • Menten AI
  • GUBRA
  • Creative Peptides
  • Exscalate
  • Generate Biomedicines
  • Receptor.AI
  • Insilico Medicine
  • Schrödinger
  • BenevolentAI
  • Evotec
  • PeptiFinder
  • Xtalpi
  • Sun Novo
  • Zonsen Peplib Biotech
  • Tide Tron Biotech

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 AI-driven Peptide Drug Discovery Platform by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Design and Generation Platform
  5. 2.2.3 Screening and Optimization Platform
  6. 2.2.4 Data-driven Platform
  7. 2.2.5 Others
  8. 2.3 AI-driven Peptide Drug Discovery Platform by Application
  9. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  10. 2.3.2 Scientific Research
  11. 2.3.3 Pharmaceuticals
  12. 2.4 Assumptions and Limitations
3 AI-driven Peptide Drug Discovery Platform Breakdown Data by Type
  1. 3.1 Global AI-driven Peptide Drug Discovery Platform Historic Market Size by Type (2021-2026)
  2. 3.2 Global AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Type (2027-2032)
4 AI-driven Peptide Drug Discovery Platform Breakdown Data by Application
  1. 4.1 Global AI-driven Peptide Drug Discovery Platform Historic Market Size by Application (2021-2026)
  2. 4.2 Global AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global AI-driven Peptide Drug Discovery Platform Market Perspective (2021-2032)
  2. 5.2 Global AI-driven Peptide Drug Discovery Platform Growth Trends by Region
  3. 5.2.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 AI-driven Peptide Drug Discovery Platform Historic Market Size by Region (2021-2026)
  5. 5.2.3 AI-driven Peptide Drug Discovery Platform Forecasted Market Size by Region (2027-2032)
  6. 5.3 AI-driven Peptide Drug Discovery Platform Market Dynamics
  7. 5.3.1 AI-driven Peptide Drug Discovery Platform Industry Trends
  8. 5.3.2 AI-driven Peptide Drug Discovery Platform Market Drivers
  9. 5.3.3 AI-driven Peptide Drug Discovery Platform Market Challenges
  10. 5.3.4 AI-driven Peptide Drug Discovery Platform Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top AI-driven Peptide Drug Discovery Platform Players by Revenue
  2. 6.1.1 Global Top AI-driven Peptide Drug Discovery Platform Players by Revenue (2021-2026)
  3. 6.1.2 Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Players (2021-2026)
  4. 6.2 Global AI-driven Peptide Drug Discovery Platform Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of AI-driven Peptide Drug Discovery Platform Head Office and Area Served
  6. 6.4 Global AI-driven Peptide Drug Discovery Platform Players, Product Type & Application
  7. 6.5 Global AI-driven Peptide Drug Discovery Platform Manufacturers Established Date
  8. 6.6 Global AI-driven Peptide Drug Discovery Platform Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  2. 7.2 North America AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  4. 7.4 North America AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  2. 8.2 Europe AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  4. 8.4 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  2. 9.2 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  2. 10.2 South America AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  4. 10.4 South America AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size (2021-2032)
  2. 11.2 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa AI-driven Peptide Drug Discovery Platform Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Peptilogics
  2. 12.1.1 Peptilogics Company Information
  3. 12.1.2 Peptilogics Business Overview
  4. 12.1.3 Peptilogics Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  5. 12.1.4 Peptilogics AI-driven Peptide Drug Discovery Platform Product Portfolio
  6. 12.1.5 Peptilogics Recent Developments
  7. 12.2 Pepticom Ltd
  8. 12.2.1 Pepticom Ltd Company Information
  9. 12.2.2 Pepticom Ltd Business Overview
  10. 12.2.3 Pepticom Ltd Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  11. 12.2.4 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Portfolio
  12. 12.2.5 Pepticom Ltd Recent Developments
  13. 12.3 Menten AI
  14. 12.3.1 Menten AI Company Information
  15. 12.3.2 Menten AI Business Overview
  16. 12.3.3 Menten AI Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  17. 12.3.4 Menten AI AI-driven Peptide Drug Discovery Platform Product Portfolio
  18. 12.3.5 Menten AI Recent Developments
  19. 12.4 GUBRA
  20. 12.4.1 GUBRA Company Information
  21. 12.4.2 GUBRA Business Overview
  22. 12.4.3 GUBRA Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  23. 12.4.4 GUBRA AI-driven Peptide Drug Discovery Platform Product Portfolio
  24. 12.4.5 GUBRA Recent Developments
  25. 12.5 Creative Peptides
  26. 12.5.1 Creative Peptides Company Information
  27. 12.5.2 Creative Peptides Business Overview
  28. 12.5.3 Creative Peptides Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  29. 12.5.4 Creative Peptides AI-driven Peptide Drug Discovery Platform Product Portfolio
  30. 12.5.5 Creative Peptides Recent Developments
  31. 12.6 Exscalate
  32. 12.6.1 Exscalate Company Information
  33. 12.6.2 Exscalate Business Overview
  34. 12.6.3 Exscalate Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  35. 12.6.4 Exscalate AI-driven Peptide Drug Discovery Platform Product Portfolio
  36. 12.6.5 Exscalate Recent Developments
  37. 12.7 Generate Biomedicines
  38. 12.7.1 Generate Biomedicines Company Information
  39. 12.7.2 Generate Biomedicines Business Overview
  40. 12.7.3 Generate Biomedicines Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  41. 12.7.4 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Portfolio
  42. 12.7.5 Generate Biomedicines Recent Developments
  43. 12.8 Receptor.AI
  44. 12.8.1 Receptor.AI Company Information
  45. 12.8.2 Receptor.AI Business Overview
  46. 12.8.3 Receptor.AI Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  47. 12.8.4 Receptor.AI AI-driven Peptide Drug Discovery Platform Product Portfolio
  48. 12.8.5 Receptor.AI Recent Developments
  49. 12.9 Insilico Medicine
  50. 12.9.1 Insilico Medicine Company Information
  51. 12.9.2 Insilico Medicine Business Overview
  52. 12.9.3 Insilico Medicine Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  53. 12.9.4 Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Portfolio
  54. 12.9.5 Insilico Medicine Recent Developments
  55. 12.10 Schrödinger
  56. 12.10.1 Schrödinger Company Information
  57. 12.10.2 Schrödinger Business Overview
  58. 12.10.3 Schrödinger Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  59. 12.10.4 Schrödinger AI-driven Peptide Drug Discovery Platform Product Portfolio
  60. 12.10.5 Schrödinger Recent Developments
  61. 12.11 BenevolentAI
  62. 12.11.1 BenevolentAI Company Information
  63. 12.11.2 BenevolentAI Business Overview
  64. 12.11.3 BenevolentAI Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  65. 12.11.4 BenevolentAI AI-driven Peptide Drug Discovery Platform Product Portfolio
  66. 12.11.5 BenevolentAI Recent Developments
  67. 12.12 Evotec
  68. 12.12.1 Evotec Company Information
  69. 12.12.2 Evotec Business Overview
  70. 12.12.3 Evotec Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  71. 12.12.4 Evotec AI-driven Peptide Drug Discovery Platform Product Portfolio
  72. 12.12.5 Evotec Recent Developments
  73. 12.13 PeptiFinder
  74. 12.13.1 PeptiFinder Company Information
  75. 12.13.2 PeptiFinder Business Overview
  76. 12.13.3 PeptiFinder Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  77. 12.13.4 PeptiFinder AI-driven Peptide Drug Discovery Platform Product Portfolio
  78. 12.13.5 PeptiFinder Recent Developments
  79. 12.14 Xtalpi
  80. 12.14.1 Xtalpi Company Information
  81. 12.14.2 Xtalpi Business Overview
  82. 12.14.3 Xtalpi Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  83. 12.14.4 Xtalpi AI-driven Peptide Drug Discovery Platform Product Portfolio
  84. 12.14.5 Xtalpi Recent Developments
  85. 12.15 Sun Novo
  86. 12.15.1 Sun Novo Company Information
  87. 12.15.2 Sun Novo Business Overview
  88. 12.15.3 Sun Novo Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  89. 12.15.4 Sun Novo AI-driven Peptide Drug Discovery Platform Product Portfolio
  90. 12.15.5 Sun Novo Recent Developments
  91. 12.16 Zonsen Peplib Biotech
  92. 12.16.1 Zonsen Peplib Biotech Company Information
  93. 12.16.2 Zonsen Peplib Biotech Business Overview
  94. 12.16.3 Zonsen Peplib Biotech Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  95. 12.16.4 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio
  96. 12.16.5 Zonsen Peplib Biotech Recent Developments
  97. 12.17 Tide Tron Biotech
  98. 12.17.1 Tide Tron Biotech Company Information
  99. 12.17.2 Tide Tron Biotech Business Overview
  100. 12.17.3 Tide Tron Biotech Revenue in AI-driven Peptide Drug Discovery Platform Business (2021-2026)
  101. 12.17.4 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio
  102. 12.17.5 Tide Tron Biotech Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst